Publisher
Deutscher Arzte-Verlag GmbH
Reference47 articles.
1. Paving the way for personalized medicine, FDA’s role in a new era of medical product development. 2013; http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/PersonalizedMedicine/UCM372421.pdf (last accessed on XX Xxxxxxx XXXX).
2. Hamburg MA, Collins FS: The path to personalized medicine. N Engl J Med 2010; 363 (4): 301–4.
3. Bousquet J, Jorgensen C, Dauzat M, Cesario A, Camuzat T, Bourret R, et al.: Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. Curr Pharm Des 2014; 20 (38): 5928–44.
4. Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Drevinek P, et al.: A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011; 365 (18): 1663–72.
5. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015; 372 (9): 793–5.